Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue
+28.9%
EPS
−17.3%
Free cash flow
+220.1%
Total debt
+47.7%

Quarter to June 2026, against a year earlier

152.16 2.29 +1.53%
Market cap
$6.5B
P/E
0.0×
Fwd P/E
37.4×
Dividend yield
0.89%
F-score
5/9
Altman Z
2.04
Beneish M
−2.21
Dividend safety
20/100

Teleflex Incorporated (TFX) Shares outstanding

Alert me on Shares outstanding

Teleflex Incorporated's shares outstanding at the end of fiscal 2025 was $44.7M, down 5.03% from $47.1M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $43.7M. Over the past ten years it has ranged from $44.7M (fiscal 2025) to $48.1M (fiscal 2015) — the current reading is the lowest in ten years. Teleflex Incorporated ranks 32nd of 47 Medical Instruments & Supplies companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $44.7M (5.03%)
FY2024 $47.1M (0.44%)
FY2023 $47.3M (0.01%)
FY2022 $47.3M (0.25%)
FY2021 $47.4M 0.30%
FY2020 $47.3M 0.42%
FY2019 $47.1M 0.62%
FY2018 $46.8M 0.29%
FY2017 $46.7M (2.06%)
FY2016 $47.6M (0.86%)

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $43.7M (1.35%)
Mar 2026 $44.3M (1.04%)
Dec 2025 $44.7M 1.10%
Sep 2025 $44.2M (0.21%)
42 more quarters

Against its own ten years

Low $44.7M High $48.1M
Ten-year median $47.3M
Current reading's percentile 9

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on TFX